WHOCC
Postal address:
WHO Collaborating Centre for Drug Statistics Methodology
Norwegian Institute of Public Health
Postboks 222 Skøyen
0213 Oslo
Norway

Visiting/delivery address:
Sandakerveien 24C
Bygg C
0473 Oslo
Norway

Tel:  +47 21 07 81 60
E-mail:
 
Copyright/Disclaimer

ATC/DDD alterations 2021

ATC alterations

Previous ATC codeATC level name New ATC code
J05AX08raltegravirJ05AJ01
J05AX11elvitegravirJ05AJ02
J05AX12dolutegravirJ05AJ03
L01XEProtein kinase inhibitors deleted
L01XE01imatinibL01EA01
L01XE02gefitinibL01EB01
L01XE03erlotinibL01EB02
L01XE04sunitinibL01EX01
L01XE05sorafenibL01EX02
L01XE06dasatinibL01EA02
L01XE07lapatinibL01EH01
L01XE08nilotinibL01EA03
L01XE09temsirolimusL01EG01
L01XE10everolimusL01EG02
L01XE11pazopanibL01EX03
L01XE12vandetanibL01EX04
L01XE13afatinibL01EB03
L01XE14bosutinibL01EA04
L01XE15vemurafenibL01EC01
L01XE16crizotinib L01ED01
L01XE17axitinibL01EK01
L01XE18ruxolitinibL01EJ01
L01XE19ridaforolimusL01EG03
L01XE21regorafenibL01EX05
L01XE22masitinibL01EX06
L01XE23dabrafenibL01EC02
L01XE24ponatinibL01EA05
L01XE25trametinibL01EE01
L01XE26cabozantinibL01EX07
L01XE27ibrutinibL01EL01
L01XE28ceritinibL01ED02
L01XE29lenvatinibL01EX08
L01XE31nintedanibL01EX09
L01XE32cediranibL01EK02
L01XE33palbociclibL01EF01
L01XE34tivozanibL01EK03
L01XE35osimertinibL01EB04
L01XE36alectinibL01ED03
L01XE37rociletinibL01EB05
L01XE38cobimetinibL01EE02
L01XE39midostaurinL01EX10
L01XE40olmutinibL01EB06
L01XE41binimetinibL01EE03
L01XE42ribociclibL01EF02
L01XE43brigatinibL01ED04
L01XE44lorlatinibL01ED05
L01XE45neratinibL01EH02
L01XE46encorafenibL01EC03
L01XE47dacomitinibL01EB07
L01XE48icotinibL01EB08
L01XE50abemaciclibL01EF03
L01XE51acalabrutinibL01EL02
L01XE52quizartinibL01EX11
L01XE53larotrectinibL01EX12
L01XE54gilteritinibL01EX13
L01XE56entrectinibL01EX14
L01XE57fedratinibL01EJ02
L01XX14tretinoinL01XF01
L01XX17topotecanL01CE01
L01XX19irinotecanL01CE02
L01XX22alitretinoinL01XF02
L01XX25bexaroteneL01XF03
L01XX32bortezomibL01XG01
L01XX38vorinostatL01XH01
L01XX39romidepsinL01XH02
L01XX42panobinostatL01XH03
L01XX43vismodegibL01XJ01
L01XX45carfilzomibL01XG02
L01XX46olaparibL01XK01
L01XX47idelalisibL01EM01
L01XX48sonidegibL01XJ02
L01XX49belinostatL01XH04
L01XX50ixazomib L01XG03
L01XX54niraparib L01XK02
L01XX55rucaparib L01XK03
L01XX56etirinotecan pegol L01CE03
L01XX60talazoparibL01XK04
L01XX61copanlisibL01EM02
L01XX63glasdegibL01XJ03
L01XX64entinostatL01XH05
L01XX65alpelisibL01EM03
L01XX68belotecanL01CE04

Other ATC alterations

ATC codePrevious ATC level name New ATC level name or new ATC level
C10BAHMG CoA reductase inhibitors in combination with other lipid modifying agentsCombinations of various lipid modifying agents
C10BXHMG CoA reductase inhibitors, other combinationsLipid modifying agents in combination with other drugs
J07BX01smallpox, live attenuatedsmallpox vaccines
P01BF04artesunate, sulphamethopyrazine and pyrimethamineartesunate, sulfalene and pyrimethamine

DDD alterations

ATC codeATC level name Previous DDD New DDD
No DDD alterations 2021

Last updated: 2020-11-27